セロトニン受容体の脂質およびリガンド調節に関する構造的洞察
Peiyu Xu1,2,3, Sijie Huang2,3,4, Huibing Zhang1,5,6,7
1Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Nature
|March 25, 2021
まとめ
セロトニン (5-HT) 受容体の構造に関する洞察は,脂質と水分子がそれらの活動をどのように調節するかを明らかにする. この研究は,これらの重要なGタンパク質結合受容体における5HTパナアゴニズムと薬物認識の背後にあるメカニズムを明らかにします.
科学分野:
- 生化学と構造生物学
- 神経科学
- 薬理学について
背景:
- セロトニン (5-ヒドロキシトリプトミン,5-HT) は,Gタンパク質結合受容体 (GPCRs) を通じて多くの生理学的プロセスを調節する重要な神経伝達物質である.
- 5-HT受容体は重要な基礎活性を示し,脂質によって調節されますが,これらの現象と5-HTの広範なアゴニズムの構造的基礎は不明のままです.
- これらのメカニズムの理解は,様々な疾患の標的治療の開発に不可欠です.
研究 の 目的:
- 5-HT GPCRsの脂質および水分調節の構造的基礎を解明する.
- 異なる受容体サブタイプにおける5-HTのパンアゴニズムの基礎となる構造的メカニズムを理解する.
- 5-HT受容体結合ポケット内の薬物認識のための構造的決定因子を特定する.
主な方法:
- クリオ電子顕微鏡を用いて,5HT受容体-Gタンパク質複合体の5つの異なる構造を決定した.
- セロトニン (5-HT),抗精神病薬アリピプラゾール,および選択性アゴニスト (BRL-54443) が5-HT受容体サブタイプ (5-HT1A,5-HT1D,5-HT1E) との相互作用を調査した.
- リピドの役割,特にフォスファチチドリノシトール4酸化物とコレステロール,および受容体活性化とリガンド結合における構造水分子を分析した.
主要な成果:
- 5-HT1A-Gタンパク質のインターフェースに フォスファチチルイノシトール4酸化物が存在し,受容体の活性が強化された.
- アリピプラゾルの特異性を影響する,5-HT1Aのリガンド結合ポケットの形成におけるコレステロールの役割が示された.
- 基礎活性化に寄与する,アポ-5-HT1A結合ポケット内の構造化された水分を特定した.
結論:
- 脂質と水分子は,5-HT GPCRの基礎活性,リガンド結合,および特異性を調節する上で重要な役割を果たします.
- 構造的な発見は,5-HTのパンアゴニスト作用のメカニズム的な説明を提供する.
- これらの洞察は,5-HT受容体を標的とする新薬の合理的な設計のための構造的基盤を提供します.
関連する概念動画
G-protein Coupled Receptors
128.0K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
128.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.2K
Ligand Binding Sites
14.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.4K
Ligand Binding Sites
8.3K
8.3K
The Two-State Receptor Model
2.8K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.8K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
571
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
571


